Journal of Research in Medical Sciences

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 26  |  Issue : 1  |  Page : 103-

Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19


Maryam Mobini1, Roya Ghasemian2, Laleh Vahedi Larijani3, Maede Mataji4, Iradj Maleki5 
1 Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran
2 Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, Iran
3 Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran
4 Department of Internal Medicine, Mazandaran University of Medical Sciences, Sari, Iran
5 Gut and Liver Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Correspondence Address:
Dr. Iradj Maleki
Endoscopy Unit, Imam Khomeini Hospital, Amir Mazandarani Street, Sari
Iran

Background: The cause of coronavirus disease 2019 (COVID-19) is a virus which can lead to severe acute respiratory syndrome-CoV-2 (SARS-COV-2). There are evidences of involvement of immune system in pathogenesis of this disease. We investigated the presence of various vasculitis-associated autoantibodies and complement levels in patients with COVID-19. Materials and Methods: Patients with severe or critical type of COVID-19 were evaluated for symptoms, signs, and laboratory tests of vasculitis syndromes including rheumatoid factor (RF), antinuclear antibody (ANA), anti-double-stranded DNA, c and p anti-neutrophilic cytoplasmic antibody (c ANCA and P ANCA), and complement levels. Results: The study was performed in forty patients with severe or critical illness. The mean age of the participants was 48.5 ± 9.8 years. All patients had pulmonary involvement in lung computed tomography scans. Vasculitis laboratory test results included RF in two patients, ANA in three patients, and ANCA in one patient. Seventeen (42.5%) patients had hypocomplementemia in one or more complement tests. Four patients expired, of whom three had a decrease in complement level. Conclusion: Decrease in complement levels may predict a critical state of COVID-19 disease. Therefore, measuring its levels may be of great benefit in making earlier decisions to initiate disease-suppressing treatments including corticosteroids.


How to cite this article:
Mobini M, Ghasemian R, Vahedi Larijani L, Mataji M, Maleki I. Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.J Res Med Sci 2021;26:103-103


How to cite this URL:
Mobini M, Ghasemian R, Vahedi Larijani L, Mataji M, Maleki I. Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19. J Res Med Sci [serial online] 2021 [cited 2021 Dec 5 ];26:103-103
Available from: https://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=103;epage=103;aulast=Mobini;type=0